Loading...
Loading...
Among the 4 tracked institutional investors we monitor, COAG (HEMAB THERAPEUTICS HOLDINGS) is held with a combined value of $450.95M across 12,277,504 shares. The largest holder is RA CAPITAL MANAGEMENT, L.P. with a position worth $286.81M (2.49% of their portfolio). 4 funds opened new positions in the most recent quarter.
Total Institutional Value
$450.95M
Total Shares Held
12,277,504
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $286.81M | 3.04% | New |
| 2 | FMR LLC | $135.82M | 0.01% | New |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | $27.40M | 0.00% | New |
| 4 | SOROS FUND MANAGEMENT LLC | $918.25K | 0.01% | New |
As of the latest SEC 13F filings, RA CAPITAL MANAGEMENT, L.P. is the largest institutional holder of COAG with a position worth $286.81M, representing 3.04% of their portfolio. In total, 4 institutional investors hold COAG with a combined value of $450.95M.
In the most recent quarter, 4 funds opened a new position in COAG.
Institutional investors hold $450.95M worth of COAG stock across 4 positions. The largest institutional holder is RA CAPITAL MANAGEMENT, L.P. with $286.81M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For COAG, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their COAG positions.
| 2026-08-14 |
| 7.7% | 2026-08-12 |
| 4.9% | 2026-08-07 |
| 7.9% | 2026-08-06 |
| 5.4% | 2026-08-05 |
SEC Schedule 13D (activist) and 13G (passive) filings for COAG. Filed when an investor acquires 5%+ ownership.
Last Close
$52.44
2026-08-18
YTD
+54.2%
92% of 52-week range